{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:58:21Z","timestamp":1778126301395,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This research was conducted to confirm the validity and reliability and to assess the responsiveness and clinical meaningfulness of the OnyCOE-t<jats:sup>\u2122<\/jats:sup>, a questionnaire specifically designed to measure patient-reported outcomes (PRO) associated with toenail onychomycosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>504 patients with toenail onychomycosis randomized to receive 12 weeks of terbinafine 250 mg\/day with or without target toenail debridement in the IRON-CLAD<jats:sup>\u00ae<\/jats:sup> trial completed the OnyCOE-t\u2122 at baseline, weeks 6, 12, 24, and 48. The OnyCOE-t\u2122 is composed of 6 multi-item scales and 1 single-item scale. These include a 7-item Toenail Symptom assessment, which comprises both Symptom Frequency and Symptom Bothersomeness scales; an 8-item Appearance Problems scale; a 7-item Physical Activities Problems scale; a 1-item Overall Problem scale; a 7-item Stigma scale; and a 3-item Treatment Satisfaction scale. In total, 33 toenail onychomycosis-specific items are included in the OnyCOE-t\u2122. Clinical data, in particular the percent clearing of mycotic involvement in the target toenail, and OnyCOE-t\u2122 responses were used to evaluate the questionnaire's reliability, validity, responsiveness, and the minimally clinical important difference (MCID).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The OnyCOE-t\u2122 was shown to be reliable and valid. Construct validity and known groups validity were acceptable. Internal consistency reliability of multi-item scales was demonstrated by Cronbach's alpha &gt; .84. Responsiveness was good, with the Treatment Satisfaction, Symptom Frequency, Overall Problem, and Appearance Problem scales demonstrating the most responsiveness (Guyatt's statistic of 1.72, 1.31, 1.13, and 1.11, respectively). MCID was evaluated for three different clinical measures, and indicated that approximately an 8.5-point change (on a 0 to 100 scale) was clinically meaningful based on a 25% improvement in target nail clearing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The OnyCOE-t\u2122 questionnaire is a unique, toenail-specific PRO questionnaire that can be used with confidence in future studies of toenail onychomycosis. MCID was evaluated for three different clinical measures, and indicated that approximately a 7-point change (on a 0 to 100 scale) was clinically meaningful based on a 12.5% improvement in target nail clearing.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7525-4-50","type":"journal-article","created":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T18:15:17Z","timestamp":1155665717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The OnyCOE-t\u2122 questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis"],"prefix":"10.1186","volume":"4","author":[{"given":"Lori P","family":"Potter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan D","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Raut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Kianifard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Tavakkol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,8,15]]},"reference":[{"issue":"10","key":"284_CR1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1046\/j.1365-4362.1997.00163.x","volume":"36","author":"BE Elewski","year":"1997","unstructured":"Elewski BE: The effect of toenail onychomycosis on patient quality of life. Int J Dermatol 1997,36(10):754\u2013756. 10.1046\/j.1365-4362.1997.00163.x","journal-title":"Int J Dermatol"},{"key":"284_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-2133.1994.tb06087.x","volume":"130 Suppl 43","author":"RK Scher","year":"1994","unstructured":"Scher RK: Onychomycosis is more than a cosmetic problem. Br J Dermatol 1994, 130 Suppl 43: 15. 10.1111\/j.1365-2133.1994.tb06087.x","journal-title":"Br J Dermatol"},{"issue":"5","key":"284_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/BF00449429","volume":"2","author":"DP Lubeck","year":"1993","unstructured":"Lubeck DP, Patrick DL, McNulty P, Fifer SK, Birnbaum J: Quality of life of persons with onychomycosis. Qual Life Res 1993,2(5):341\u2013348. 10.1007\/BF00449429","journal-title":"Qual Life Res"},{"issue":"1-2","key":"284_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1023\/A:1026429012353","volume":"8","author":"DP Lubeck","year":"1999","unstructured":"Lubeck DP, Gause D, Schein JR, Prebil LE, Potter LP: A health-related quality of life measure for use in patients with onychomycosis: a validation study. Qual Life Res 1999,8(1\u20132):121\u2013129. 10.1023\/A:1026429012353","journal-title":"Qual Life Res"},{"issue":"2 Pt 1","key":"284_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0190-9622(99)70047-2","volume":"41","author":"LA Drake","year":"1999","unstructured":"Drake LA, Patrick DL, Fleckman P, Andr J, Baran R, Haneke E, Sapede C, Tosti A: The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 1999,41(2 Pt 1):189\u2013196. 10.1016\/S0190-9622(99)70047-2","journal-title":"J Am Acad Dermatol"},{"issue":"5 Pt 1","key":"284_CR6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0190-9622(98)70199-9","volume":"38","author":"LA Drake","year":"1998","unstructured":"Drake LA, Scher RK, Smith EB, Faich GA, Smith SL, Hong JJ, Stiller MJ: Effect of onychomycosis on quality of life. J Am Acad Dermatol 1998,38(5 Pt 1):702\u2013704. 10.1016\/S0190-9622(98)70199-9","journal-title":"J Am Acad Dermatol"},{"key":"284_CR7","first-page":"297","volume-title":"Exploratory Variable Clustering for Integrating Analyses: San Francisco, CA.","author":"DJ Pasta","year":"1996","unstructured":"Pasta DJ, Potter LP: Exploratory Variable Clustering for Integrating Analyses: San Francisco, CA. ; 1996:297\u2013301."},{"key":"284_CR8","first-page":"297","volume-title":"Coefficient alpha and the internal structure of tests","author":"LJ Cronbach","year":"1951","unstructured":"Cronbach LJ: Coefficient alpha and the internal structure of tests. Volume 16. Psychometrika; 1951:297\u2013334."},{"issue":"8","key":"284_CR9","first-page":"889","volume":"134","author":"GH Guyatt","year":"1986","unstructured":"Guyatt GH, Bombardier C, Tugwell PX: Measuring disease-specific quality of life in clinical trials. Cmaj 1986,134(8):889\u2013895.","journal-title":"Cmaj"},{"issue":"2","key":"284_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0021-9681(87)90069-5","volume":"40","author":"G Guyatt","year":"1987","unstructured":"Guyatt G, Walter S, Norman G: Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 1987,40(2):171\u2013178. 10.1016\/0021-9681(87)90069-5","journal-title":"J Chronic Dis"},{"key":"284_CR11","volume-title":"The OnyCOE-t Questionnaire: Reliability and Validity of a Patient Reported Outcomes Questionnaire: October 19-22; San Francisco, CA.","author":"LP Potter","year":"2005","unstructured":"Potter LP, Mathias SD: The OnyCOE-t Questionnaire: Reliability and Validity of a Patient Reported Outcomes Questionnaire: October 19\u201322; San Francisco, CA. ; 2005."},{"key":"284_CR12","unstructured":"Assessing health status and quality-of-life instruments: attributes and review criteria Qual Life Res 2002,11(3):193\u2013205. 10.1023\/A:1015291021312"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7525-4-50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T23:31:11Z","timestamp":1630452671000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/1477-7525-4-50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,15]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["284"],"URL":"https:\/\/doi.org\/10.1186\/1477-7525-4-50","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,15]]},"assertion":[{"value":"25 March 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"50"}}